Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis

International Angiology

Volumn 28, Issue 3, 2009, Pages 192-201

  Kluz, J ^a   Kopec W ^a   Jakobsche Policht, U ^a   Adamiec, R ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; Endothelium, vascular; Lupus erythematosus, systemic; Selectins; Vasculitis

Indexed keywords

CD146 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; CELL ADHESION MOLECULE;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MICROANGIOPATHY; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CELL COUNT; COMPLICATION; IMMUNOMAGNETIC SEPARATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POLAND; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL COUNT; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; INTERCELLULAR ADHESION MOLECULE-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLAND; SEVERITY OF ILLNESS INDEX; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS; YOUNG ADULT;

EID: 69549107381     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Nagy G, Brózik M, Varga L, Fust G, Kirschfink M, Kiss E et al. Usefullness of detection of complement activation products in evaluating SLE activity. Lupus 2000;9:19-25. (Pubitemid 30265114)
2. Guillevin L, Dörner T. Vasculitis: mechanisms involved and clinical manifestations. Arthritis Res Ther 2007;9 Suppl 2:S9.
3. Rose DM, Alon R, Ginsberg MH. Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev 2007;218:126-134 (Pubitemid 47052306)
4. Constans J, Dupuy R, Blann AD, Resplandy F, Seigneur M, Renard M et al. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus. J Rheumatol 2003;30:1963-1966 (Pubitemid 37075545)
5. Del Papa N, Raschi E, Moroni G, Panzeri P, Borgii MO, Ponticelli C et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cell and induce a pro- adhesive and pro-inflammatory phenotype in vitro. Lupus 1999;8:423-429 (Pubitemid 29423575)
6. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG: Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol 1994;7:439-444 (Pubitemid 24283887)
7. Pallis M, Robson DK, Haskard DO, Powell RJ. Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis 1993;52:667-671 (Pubitemid 23280436)
8. McHale JF, Harari OA, Marshall D, Haskard DO. TNF-alpha and IL-1 sequentially induce ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol 1999;163:3993-4000. (Pubitemid 29450929)
9. Takeuchi T, Amano K, Sekine H, Koide J, Abe T. Upregulated expression and function of the integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J Clin Invest 1993;92:3008-3016 (Pubitemid 24006572)
10. Kevil CG, Hicks MJ, He X, Zhang J, Ballantyne CM, Raman C et al. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Faslpr mice from autoimmune disease. Am J Pathol 2004;165:609-616 (Pubitemid 38971390)
11. Bullard DC, King PD, Hicks MJ, Dupont B, Beaudet al, Elkon KB. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Faslpr mice from early lethality. J Immunol 1997;159:2058-2067 (Pubitemid 127484198)
12. James WG, Bullard DC, Hickey MJ. Critical role of the alpha(4) Integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice. J Immunol 2003;170:520-527
13. Hickey MJ, Bullard DC, Issekutz A, James WG. Leukocyte-endothelial cell interactions are enhanced in dermal postcapillary venules of MRL/faslpr (lupus-prone) mice: roles of P-and E-selectin. J Immunol 2002;168:4728-4736 (Pubitemid 34441381)
14. Roman MJ, Shanker BE, Davis A, Lockshin MD, Sammaritano L, Simantov R et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. Engl J Med 2003;349:2399-2406
15. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-415 (Pubitemid 27084212)
16. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-519
17. Frostegard J. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005;257:485-495
18. Clancy R, Marder G, Martin V, Belmont M, Abramson SB, Buyon J. Circulating activated endothelial cells in systemic lupus erythematosus: Further evidence for diffuse vasculopathy. Arthritis Rheum 2001;44:1203-1208 (Pubitemid 32433629)
19. Sesin CA, Xiaoming Y, Esmon CT, Buyon JP, Clancy RM. Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: in vivo and in vitro evidence. Kidney Intern 2005;68:110-120 (Pubitemid 43181368)
20. Rajagopalan S, Somers EC, Brook RD, Kehrer C, Pfenninger D, Lewis E et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 2004;103:3677-3683
21. ?tefanec T. Endothelial apoptosis: the missing link between atherosclerosis and SLE? Blood 2004;103:3608-3609
22. Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv Clin Chem 2006;42:297-326. (Pubitemid 44302111)
23. Meroni PL, Del Papa N, Raschi E, Panzeri P, Borghi MO, Tincani A et al. β2-glycoprotein I as a 'cofactor' for antiphospholipid reactivity with endothelial cells. Lupus 1998;7:S44-47.
24. Tedgui A, Mallat Z. Apoptosis is a determinant of atherothrombosis. Thromb Haemost 2001;86:420-426
25. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003;361:206-210 (Pubitemid 36126220)
26. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003;131:536-540
27. Woywodt A, Scheer J, Hambach L, Buchholz S, Ganser A, Haller H et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem-cell transplantation. Blood 2004;103:3603-3605 (Pubitemid 38525700)
28. Camoin-Jau L, Chabrol B, Sampol J, Dignat-George F. Circulating endothelial cells in Behçet's disease with cerebral thrombophlebitis. Thromb Haemost 2000;83:631-632 (Pubitemid 30201145)
29. Haubitz M, Woywodt A. Circulating endothelial cells and vasculitis. Intern Med 2004;43:660-667
30. Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004;50:1296-1304 (Pubitemid 38480841)
31. Makin AJ, Blann AD, Chung NAY, Silverman SH, Lip GYH. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells: relationship with von Willebrand factor and tissue factor. Eur Heart J 2004;25:371-376
32. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 2003;90:698-703. (Pubitemid 37287638)
33. Woywodt A, Schröder M, Gwinner W, Mengel M, Jaeger M, Schwarz A et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 2003;76:1-4. (Pubitemid 36877106)
34. Lee KW, Lip GYH, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005;105:526-532 (Pubitemid 40070731)
35. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon J, Clancy RM et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005;93:228-235
36. Grootscholten C, van Bruggen MC, van der Pijl JW, de Jong EM, Ligtenberg G, Derksen RH et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003;48:1355-1362 (Pubitemid 36554534)
37. Dieker JWC, van der Viag J, Berden JHM. Deranged removal of apoptotic cells: its role in the genesis of lupus. Nephrol Dial Transplant 2004;19:282-285
38. Zykova SN, Seredkina NE, Rekvig OP. Glomerular targets for autoantibodies in lupus nephritis-an apoptotic origin. Ann NY Acad Sci 2007;1108:1-10.
39. Cairns AP, Crockard AD, McConnell JR, Courtney P, Bell A. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: Relations with apoptotic neutrophils and disease activity. Ann Rheum Dis 2001;60:950-955 (Pubitemid 32885670)
40. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-1250
41. Ekdahl KN, Bengtsson AA, Andersson J, Elgue G, Ronnblom L, Sturfelt G et al. Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation. Br J Haematol 2004;125:74-78 (Pubitemid 38453281)
42. Andreakos A: Monoclonal antibodies for immunological disorders: a review of recent patents. Expert Opin Ther Patents 2005;15:1105-1114
43. Hermosillo-Romo D, Brey RL. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract Res Clin Rheumatol 2002;16:229-244 (Pubitemid 36526641)
44. Lewis MJ, D'Cruz D. Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus. Lupus 2005;14:17-26. (Pubitemid 40460512)